396 results on '"Gunawardena, Harsha"'
Search Results
2. Diagnostic utility of N-terminal TMPP labels for unambiguous identification of clipped sites in therapeutic proteins
3. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
4. Desalting paper spray mass spectrometry (DPS-MS) for rapid detection of glycans and glycoconjugates
5. The Midpoint Mixed Model with a Missingness Mechanism (M5): A Likelihood-Based Framework for Quantification of Mass Spectrometry Proteomics Data (Preprint)
6. IgG and plasma viscosity as markers of disease activity in primary Sjogren's syndrome-related lymphocytic interstitial pneumonia.
7. THE EFFECTS OF NONIGNORABLE MISSING DATA ON LABEL-FREE MASS SPECTROMETRY PROTEOMICS EXPERIMENTS
8. The diagnosis and management of systemic autoimmune rheumatic disease-related interstitial lung disease: British Society for Rheumatology guideline scope.
9. Mobile Affinity Selection Chromatography Analysis of Therapeutic Monoclonal Antibodies
10. Novel RNA-Affinity Proteogenomics Dissects Tumor Heterogeneity for Revealing Personalized Markers in Precision Prognosis of Cancer
11. A clinical and serological study of adult and juvenile idiopathic inflammatory myopathy
12. Landscape of transcription in human cells
13. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults
14. “Lab of the Future”─Today: Fully Automated System for High-Throughput Mass Spectrometry Analysis of Biotherapeutics
15. “Stapling” scFv for multispecific biotherapeutics of superior properties
16. A Phase II randomised controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS)
17. Rapid Characterization of Antibodies via Automated Flow Injection Coupled with Online Microdroplet Reactions and Native-pH Mass Spectrometry
18. A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS)
19. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
20. 17. Anti-synthetase autoantibody is seen in patients with overlap myositis in the UK cohort of patients with Jveunile Dermatomyositis
21. Neurological Manifestations of IgG4-Related Disease
22. The Clinical Features of Myositis-Associated Autoantibodies: a Review
23. A multidisciplinary approach to the diagnosis of antisynthetase syndrome
24. The EuroMyositis registry: an international collaborative tool to facilitate myositis research
25. Rapid Screening of Ellagitannins in Natural Sources via Targeted Reporter Ion Triggered Tandem Mass Spectrometry
26. Human herpes virus-6 encephalitis causing severe anterograde amnesia associated with rituximab, azathioprine and prednisolone combination therapy for dermatomyositis
27. Standard-Free Absolute Quantitation of Antibody Deamidation Degradation and Host Cell Proteins by Coulometric Mass Spectrometry
28. Management of interstitial lung disease (ILD) in myositis syndromes: A practical guide for clinicians
29. Investigation of Tryptic Protein Digestion in Microdroplets and in Bulk Solution
30. Modulation of B-cell exosome proteins by gamma herpesvirus infection
31. P293 Tocilizumab for refractory or relapsing giant cell arteritis: audit data from the Bristol and Bath regional multidisciplinary meetings 2018-2021
32. The Evolving Spectrum of Polymyositis and Dermatomyositis—Moving Towards Clinicoserological Syndromes: A Critical Review
33. Correction: Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
34. Rheumatologists have an important role in the management of interstitial lung disease (ILD): a cross-speciality, multi-centre, UK perspective
35. Redox regulation of Rac1 by thiol oxidation
36. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset
37. Errata: Biophysical and Proteomic Characterization Strategies for Cysteine Modifications in Ras GTPases
38. Biophysical and Proteomic Characterization Strategies for Cysteine Modifications in Ras GTPases
39. An integrated encyclopedia of DNA elements in the human genome
40. Charge-dependent dissociation of insulin cations via ion/ion electron transfer
41. Lessons of the month: ANCA-associated vasculitis – granulomatosis with polyangiitis: ‘the great mimic’
42. Denovo Identification of Cross-linked Peptides via Isotope Coded Linkage Tags
43. Electron transfer dissociation of multiply protonated and fixed charge disulfide linked polypeptides
44. Phosphopeptide anion characterization via sequential charge inversion and electron-transfer dissociation
45. Microdroplet Ultrafast Reactions Speed Antibody Characterization
46. Multi-disciplinary team approach in the management of connective tissue disease-interstitial lung disease: The way forward
47. Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary fibrosis and ASyS diagnosed in rheumatology services
48. Nanoelectrospray ionization of protein mixtures: solution ph and protein pI
49. Glutathiolated Ras: Characterization and implications for Ras activation
50. British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.